5 Key Takeaways

• 1

  The FDA approved a reformulated ranitidine tablet after its removal in 2020 due to concerns over NDMA, a potential carcinogen.

• 2

  The new formulation includes stronger manufacturing controls to prevent NDMA formation during storage.

• 3

  Ranitidine is used to treat GERD, peptic ulcers, and conditions with excess acid production, similar to famotidine.

• 4

  Dr. Binu V. John stated that ranitidine does not provide greater clinical benefit compared to famotidine.

• 5

  The FDA recommends specific storage instructions for ranitidine to maintain safety and product quality.